The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline

This ESMO Guideline provides key recommendations on the role of PROMs during the care of patients with cancer. It covers the use of PROMs in patients with cancer from the start of active treatment during follow-up and at the end of life. Recommendations are based on available scientific evidence and the authors’ collective expert consensus. Authorship includes a multidisciplinary group of experts from Europe, North America, Asia and Australia.